Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Certara enters the week with a fresh analyst upgrade colliding head-on with its sharpest single-day sell-off in months, a 7.9% drop on October 6 that brought the stock back to $9.27 despite a still-positive one-month trend.
The most notable development on the analyst front is Barclays. The firm raised its price target from $7.50 to $9.00 on October 7, maintaining its Equal-Weight rating. That is a meaningful move: the prior note published here a week ago flagged the same analyst lifting targets in August following May's cuts, and the trajectory has now continued upward. UBS, meanwhile, downgraded to Neutral on September 30, keeping its $10 target. The consensus picture remains cautious. The mean target across the Street is $8.62, now below the current close of $9.27, meaning the stock has again outrun the collective analyst view. The majority of recent moves have been target raises or holds, not new conviction buys. Factor scores reflect the same ambivalence: EPS surprise ranks in the bottom 2nd percentile, and EPS momentum over 90 days sits in the 21st percentile, both weak. The PE multiple has expanded roughly 3.4 points over the past 30 days to around 24.6x, and EV/EBITDA has contracted by about 1.1 turns over the same period to 13.2x, a mixed picture on valuation direction.
Short positioning remains the structural backdrop for this stock. Short interest is 17.0% of free float, essentially unchanged on the week (down 1.2%), and has been gradually declining from a peak above 20% in mid-September. The borrow market is relaxed. Cost to borrow is 0.51%, near the bottom of the past 30-day range, and availability at 255% of short interest means there is more than twice as much stock available to borrow as is currently shorted. The ORTEX short score is elevated at 71.1, in the 5th percentile for short positioning rank, but the score has drifted slightly lower from 72.4 a week ago. The direction is easing rather than building. Days-to-cover from the most recent FINRA fortnightly data came in at 15 days, a figure that commands attention even as gross short interest slowly retreats.
Options positioning has swung to a striking extreme on the bullish side. The put/call ratio hit 0.0126 on October 6, the lowest reading in the past 52 weeks. That is almost four standard deviations below the 20-day mean of 0.018, a historically anomalous lean toward calls. What makes this interesting is the timing: the reading landed on the same day the stock fell nearly 8%, suggesting options participants were not hedging into weakness but adding call exposure through it. The 52-week high on the PCR was 0.96, so the current reading represents an almost complete reversal of positioning from the most defensive extreme to the most aggressive.
The ownership register carries one genuinely newsworthy fact. Terry M. Mullen filed a Schedule 13D/A in April 2025 declaring a 22.6% stake, matching the Arsenal Capital Management position of 36.3 million shares. A Schedule 13D signals activist intent, not passive ownership. That block has not moved since March 2026 per the institutional data, but with an activist on the register holding nearly a quarter of the company and an earnings date confirmed for November 6, the ownership structure is not inert. BlackRock added 4.5 million shares in the most recently reported quarter, bringing its holding to 12.3% of shares. Those two holders together account for more than a third of the company. As always with 13D/G disclosures, stakes are as last disclosed around the 5% threshold, and positions can change without a new filing when holdings drop below that level.
The next earnings print on November 6 is the clearest near-term reference point. The two most recent post-earnings reactions were both negative: down 0.7% on the day in August and down 2.1% in the prior event, with five-day moves also negative in both cases. What to watch between now and then is whether the call-heavy options positioning holds after Tuesday's sell-off, and whether the slow decline in short interest continues or reverses as the print approaches.
See the live data behind this article on ORTEX.
Open CERT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
